Clinical Trial Update: A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating the polyvalent pneumococcal conjugate vaccine V116 in adults has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Diseases
• Pneumonia

Drugs mentioned

• V116

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumonia, Pneumococcal | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-08-02